IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Integris Medtech IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in New Delhi and caters to Pharmaceutical sector. Axis Capital , Citigroup Global Markets India , ICICI Securities , IIFL Securities are the merchant bankers of Integris Medtech IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 9th October 2025.
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,326.67 cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Axis Capital
IPO by BRLM so far:
169
City:
New Delhi
IPO so far:
130
Revenue (annualised):
₹
1941.00
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 27.74x
Integris Medtech IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
| Particulars | Amount |
|---|---|
| Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued and prepayment penalties, as applicable, availed by its wholly-owned Subsidiaries, namely, Translumina Therapeutics Private Limited, Transhealth Private Limited and HaleMed Medical Private Limited; | [●] |
| Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued and prepayment penalties, as applicable, availed by its step-down Subsidiaries, namely, CPC Diagnostics Private Limited, Chemopharm Sdn. Bhd., Chemoscience Pte Ltd., Lifeline Diagnostics Supplies Inc., Hausen Bernstein Co. Ltd, Medigene Sdn. Bhd., Research Instruments Sdn Bhd and Research Instruments Pte. Ltd | [●] |
| General corporate purposes | [●] |
Axis Capital Limited is the book-running lead manager of the Integris Medtech IPO. Kfin Technologies Limited is the Registrar for Integris Medtech IPO.
Integris Medtech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Integris Medtech IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on Offers diversified medical products and laboratory solutions company. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Integris Medtech IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Integris Medtech IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Integris Medtech IPO allotment status on the registrars website, Kfin Technologies Limited . Integris Medtech IPO refund dates are [●].
Integris Medtech IPO is expected to be listed on [●].
The upper price band for the Integris Medtech IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Integris Medtech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Integris Medtech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Integris Medtech IPO is finalised.
The merchant banker for Integris Medtech IPO is Axis Capital Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited , IIFL Securities Limited . Axis Capital Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited , IIFL Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Integris Medtech IPO RHP for further details.
The registrar for Integris Medtech IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Integris Medtech IPO through their official website or helpline.
Integris Medtech IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,326.67 Cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Axis Capital
IPO by BRLM so far:
169
City:
New Delhi
IPO so far:
130
Revenue (annualised):
₹ 1,941.00 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 27.74x
Integris Medtech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Integris Medtech Financial Review Page
Merchant Banker(s) of Integris Medtech IPO: Axis Capital Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited , IIFL Securities Limited
Integris Medtech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Integris Medtech IPO listed at a listing price of against the offer price of .
The current market price of Integris Medtech is .
Why Us?
